Aster DM Healthcare Q2 FY21 revenue up 9pc to Rs. 2,268 Crs
EBITDA up 11% at Rs. 271 Crs., PAT at Rs. 42 Crs
Bangalore: Aster DM Healthcare, one of the largest private healthcare service providers in multiple GCC countries and an emerging healthcare player in India, today announced its financial results for the quarter ended September 30, 2020.
KEY HIGHLIGHTS OF THE QUARTER
• Operational Revenue improves by 9% Y-o-Y to Rs. 2,268 Crs. compared to Rs. 2,087 Crs.
• EBITDA (excluding other income) increases by 11 % Y-o-Y to Rs. 271 Crs. compared to Rs. 245 Crs.
• PAT (Pre- Non-Controlling Interest) increases to Rs. 42 Crs. Y-o-Y compared to Rs. 7 Crs.
• PAT (Post Non-Controlling Interest) increases to Rs. 33 Crs. Y-o-Y compared to Rs. 3 Crs.
Commenting on the performance for Q2 FY21, Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, said: “The greatest pandemic mankind has ever witnessed in lifetime is still continuing with its second wave in many countries. Almost all countries have lifted their lockdown restrictions and everyone is adjusting to the ‘new normal’ despite the second wave. Our businesses have come back to normal in the GCC, however India operations are still lagging behind even though the new cases in India have dropped significantly in the last month. I believe that the innate strength in our diversified business model has helped us maintain the business amidst the pandemic situation.
As we pass this journey, some of the key learnings that have taken a permanent berth in our strategy formulation process are sustainability of the revenue streams, unwavering focus on cost control and maintaining robust liquidity in the system. I would also like to share here that the cost optimization projects which were initiated in the past two fiscals with intentions to drive in more cost efficiencies at the levels of manpower, materials and other direct expenses have helped us to become more efficient.”